These T40 fibril preparations that were amplified with AD tau extracts in vitro appeared to retain strain-like properties when used to induce tauopathy in mice, as they developed tau aggregates containing equal ratios of 3R and 4R tau, similar to the AD tau seed (80). The gene discussed is MAPT; the disease is Alzheimer disease.